Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 1, 1982
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination
S L Sacks, G H Scullard, R B Pollard, et al.
The Journal of Antimicrobial Chemotherapy
|
August 10, 2000
Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey
R J Boon, T H Bacon, H L Robey, et al.
Journal of Viral Hepatitis
|
September 11, 2004
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily
C C Wang, S Holte, M-L Huang, et al.
Antiviral Research
|
May 13, 1999
Herpes simplex virus latency and nucleoside analogues
S Efstathiou, H J Field, P D Griffiths, et al.
The Journal of Infectious Diseases
|
April 1, 1990
Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes
S L Sacks, T L Varner, K S Davies, et al.
The Journal of Infectious Diseases
|
June 1, 1981
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside
G H Scullard, R B Pollard, J L Smith, et al.
The Journal of Infectious Diseases
|
February 1, 1987
Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial
S L Sacks, J Portnoy, D Lawee, et al.
The Journal of Infectious Diseases
|
October 1, 1991
Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group
S L Sacks, L D Tyrrell, D Lawee, et al.
JAMA
|
January 5, 1979
Toxicity of vidarabine
S L Sacks, J L Smith, R B Pollard, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes
S L Sacks, S D Shafran, F Diaz-Mitoma, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Antimicrobial Agents and Chemotherapy
|
January 1, 1982
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination
S L Sacks, G H Scullard, R B Pollard, et al.
The Journal of Antimicrobial Chemotherapy
|
August 10, 2000
Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey
R J Boon, T H Bacon, H L Robey, et al.
Journal of Viral Hepatitis
|
September 11, 2004
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily
C C Wang, S Holte, M-L Huang, et al.
Antiviral Research
|
May 13, 1999
Herpes simplex virus latency and nucleoside analogues
S Efstathiou, H J Field, P D Griffiths, et al.
The Journal of Infectious Diseases
|
April 1, 1990
Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes
S L Sacks, T L Varner, K S Davies, et al.
The Journal of Infectious Diseases
|
June 1, 1981
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside
G H Scullard, R B Pollard, J L Smith, et al.
The Journal of Infectious Diseases
|
February 1, 1987
Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial
S L Sacks, J Portnoy, D Lawee, et al.
The Journal of Infectious Diseases
|
October 1, 1991
Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group
S L Sacks, L D Tyrrell, D Lawee, et al.
JAMA
|
January 5, 1979
Toxicity of vidarabine
S L Sacks, J L Smith, R B Pollard, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes
S L Sacks, S D Shafran, F Diaz-Mitoma, et al.
Page
of 6